Pneumococcal infection surveillance in Lebanon

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational program aims to identify the serotypes of Streptococcus pneumoniae responsible for invasive infections such as pneumonia, meningitis, and sepsis in Lebanon. By collecting bacterial isolates from patients across various hospitals, the study will analyze their antibiotic sensitivity and assess the effectiveness of existing pneumococcal vaccines. The findings will provide valuable insights for healthcare providers in Lebanon regarding the prevention and treatment of these serious infections.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Samples included in the study are those that are:

  * culture proven
  * invasive pneumococcal infections
  * in patients of all ages admitted to different hospitals all over Lebanon
* Acceptable samples include:

  * positive isolates from blood
  * cerebrospinal fluid
  * other normally sterile body sites such as empyema fluid, abscesses, joint fluid, middle ear fluid obtained by tympanocentesis in the operating room, and lung needle aspiration

Exclusion Criteria:

* non S. pneumoniae isolates

Where it's running

• American University of Beirut
  Beirut, Lebanon Recruiting

Study contacts

• Principal investigator: Ghassan S Dbaibo, M.D. — American University of Beirut Medical Center
• Study coordinator: Ghassan S Dbaibo, M.D.
• Email: gdbaibo@aub.edu.lb
• Phone: +961-1-749235

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• UllCORE BSI Test for Bloodstream Infections

  This study tests whether the UllCORE BSI Test can correctly detect bloodstream infection pathogens and resistance markers from whole blood in people with suspected infection or sepsis.

  Recruiting Deepull Diagnostics S.L. · Orange, California and 19 other locations · NCT07859852

• Sulbactam-Durlobactam for CRAB infections in real-world care

  This real-world study tests whether sulbactam-durlobactam works and is safe for adults with carbapenem-resistant Acinetobacter baumannii infections, compared with other anti-CRAB treatments.

  Recruiting Sichuan Provincial People's Hospital · Chengdu, Sichuan · NCT07601711

• New care guideline for infants 60 days and younger with fever in Sweden

  This project will test a new guideline to see if infants 60 days or younger with fever can safely avoid many invasive tests, hospital stays, and broad antibiotics compared with usual care.

  Recruiting at 9 sites Region Skane · Gothenburg and 10 other locations · NCT07134751

• Effects of suctioning on pain and stress in intubated ICU patients

  This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.

  Recruiting Loma Linda University · Loma Linda, California · NCT06692400

• Understanding risk factors and biomarkers in ARDS, sepsis, and pneumonia

  This study is trying to find out what causes acute respiratory distress syndrome, sepsis, and pneumonia by collecting health information and samples from hospitalized adults to help improve treatment for these conditions.

  Recruiting at 20 sites Vanderbilt University Medical Center · Fresno, California and 19 other locations · NCT06521502

• Validation of hematological indices in cardiac surgery patients

  This study is testing if certain blood test results can help predict infections and organ problems in patients who are having heart surgery.

  Recruiting Petrovsky National Research Centre of Surgery · Moscow · NCT06476171

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.